ClinicalTrials.gg
RecruitingNCT07174921Updated Sep 16, 2025

Post-hysterectomy Vaginal Cuff Prolapse Repair

An interventional study of Laparoscopic Lateral Suspension and Laparoscopic Sacrocolpopexy in Vaginal Cuff Complications, sponsored by Kanuni Sultan Suleyman Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-16.

Sponsored by Kanuni Sultan Suleyman Training and Research Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This study is a randomized controlled trial comparing two minimally invasive surgeries-laparoscopic lateral suspension and laparoscopic sacrocolporopexy-for women who develop vaginal cuff prolapse after hysterectomy. Vaginal cuff prolapse occurs when the top of the vagina loses support after the uterus is removed, which can cause discomfort, bulging, or urinary and bowel problems.

The goal of this study is to determine which surgical approach is safer, more effective, and improves quality of life for patients. Women enrolled in the trial will be randomly assigned to one of the two surgeries, and outcomes such as prolapse recurrence, complications, recovery time, and patient satisfaction will be carefully monitored.

By comparing these two techniques, this study aims to provide clear guidance for surgeons and patients to make informed decisions about the best surgical treatment for post-hysterectomy vaginal cuff prolapse.

Read the detailed description

This study is a randomized controlled trial (RCT) designed to compare the outcomes of two minimally invasive surgical techniques-laparoscopic lateral suspension and laparoscopic sacrocolpopexy-for the treatment of vaginal cuff prolapse following hysterectomy. Vaginal cuff prolapse occurs when the top of the vagina loses its normal support after the uterus has been removed, leading to symptoms such as a sensation of vaginal bulging, pelvic pressure, urinary or bowel dysfunction, and discomfort during daily activities or sexual intercourse.

Eligible participants are women who have previously undergone hysterectomy and are experiencing symptomatic vaginal cuff prolapse. Participants will be randomly assigned to undergo either laparoscopic lateral suspension or laparoscopic sacrocolpopexy. Both procedures are performed using minimally invasive laparoscopic techniques, which typically result in smaller incisions, less pain, and faster recovery compared to traditional open surgery.

The study will assess multiple clinical and patient-reported outcomes, including:

Anatomical success: Prevention of prolapse recurrence at follow-up visits.

Functional outcomes: Improvement in urinary, bowel, and sexual function.

Complications: Intraoperative and postoperative adverse events.

Recovery metrics: Length of hospital stay, return to daily activities, and postoperative pain.

Patient satisfaction: Quality of life and overall satisfaction with the procedure.

By conducting this study, researchers aim to provide evidence-based guidance on which surgical approach offers better long-term outcomes, fewer complications, and higher patient satisfaction. The results of this trial may help clinicians make informed decisions and improve the care of women with post-hysterectomy vaginal cuff prolapse.

02

Conditions studied

  • Vaginal Cuff Complications

Browse trials for

Keywords

  • prolapse
  • vaginal cuff
  • lateral suspension
  • sacrocolpopexy
03

In context

Prolapse

93 studies on the registry are indexed under Prolapse; 9 are open to participants now.

This study's planned enrollment of 50 is below the median of 70 across 65 interventional studies indexed under Prolapse.

Browse Prolapse studies →

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital is the lead sponsor of 225 studies on the registry; 35 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Women aged ≥18 years.

History of hysterectomy (any approach: abdominal, vaginal, or laparoscopic).

Symptomatic vaginal cuff prolapse (POP-Q stage ≥ II).

Able to provide written .

Willing and able to comply with study procedures and follow-up visits.

Exclusion criteria

Exclusion Criteria:

Prior sacrocolpopexy or lateral suspension surgery.

Active pelvic infection or untreated .

Severe cardiopulmonary or systemic disease that contraindicates laparoscopic surgery.

Known allergy to mesh materials used in the procedures.

Inability to complete patient-reported questionnaires due to cognitive or language barriers.

Concurrent pelvic organ prolapse requiring additional surgical repair beyond vaginal cuff suspension.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    Laparoscopic Sacrocolpopexy

    Procedure: Laparoscopic Sacrocolpopexy

  • Experimental
    Laparoscopic Lateral Suspension

    Procedure: Laparoscopic Lateral Suspension

Interventions

  • ProcedureLaparoscopic Lateral Suspension

    Participants in this arm will undergo laparoscopic lateral suspension for post-hysterectomy vaginal cuff prolapse. The procedure involves attaching a synthetic mesh from the vaginal cuff to the lateral abdominal wall to provide support and restore normal vaginal anatomy. Standard perioperative care, including anesthesia and postoperative pain management, will be provided.

    Also known as: Lateral Suspension (Apical Suspension)

  • ProcedureLaparoscopic Sacrocolpopexy

    Participants in this arm will undergo laparoscopic sacrohysteropexy for post-hysterectomy vaginal cuff prolapse. The procedure involves suspending the vaginal cuff to the sacral promontory using a synthetic mesh, restoring vaginal support. Standard perioperative care, including anesthesia and postoperative pain management, will be provided.

06

What researchers measure

Primary outcomes

  1. Anatomical Success (Point C of POP-Q System)

    Vaginal cuff support measured objectively using POP-Q system, focusing on point C (position of the vaginal apex relative to the hymen). Success is defined as point C remaining above the hymen at follow-up by a blinded examiner.

    Time frame: 12 months post-surgery

Secondary outcomes

  1. Operative Time

    Total duration of the surgery measured in minutes from incision to closure.

    Time frame: During surgery

  2. Postoperative Hospital Stay

    Length of hospital stay in days from surgery to discharge.

    Time frame: From the day of surgery through hospital discharge (an expected average of 2 days)

  3. Postoperative Complications

    Includes mesh exposure, infection, bleeding, urinary or bowel injury, and reoperation.

    Time frame: Up to 12 months post-surgery

  4. Pelvic Floor Distress Inventory (PFDI-20)

    Patient-reported measure of prolapse, urinary, and bowel symptoms. The PFDI-20 consists of 3 subscales: Pelvic Organ Prolapse Distress Inventory (POPDI-6) Colorectal-Anal Distress Inventory (CRADI-8) Urinary Distress Inventory (UDI-6) Each subscale is scored 0-100, and the total score is the sum of the three subscales (0-300). 0 = no pelvic floor-related distress at all. 300 = the maximum possible distress, meaning the respondent endorsed the highest level of bother on all 20 items.

    Time frame: Preoperative and 12 months post-surgery

  5. Pelvic Floor Impact Questionnaire (PFIQ-7)

    Patient-reported measure of the impact of pelvic floor disorders on daily activities, relationships, and quality of life. The PFIQ-7 includes 3 subscales: Urinary Impact Questionnaire (UIQ-7) Colorectal-Anal Impact Questionnaire (CRAIQ-7) Pelvic Organ Prolapse Impact Questionnaire (POPIQ-7) Each subscale contains items scored 0-3 ("not at all" to "quite a bit"), then converted to a 0-100 scale. The three subscales are summed for a total score ranging from 0 to 300. 0 = no impact on quality of life. 300 = maximum impact across all domains (urinary, colorectal-anal, and prolapse). Higher scores indicate worse quality-of-life impairment due to pelvic floor disorders.

    Time frame: Preoperative and 12 months post-surgery

  6. Patient Global Impression (PGI) Scale

    Patient-reported scale evaluating overall improvement or satisfaction with surgery, typically rated from 1 ("very much improved") to 7 ("very much worse").

    Time frame: Preoperative and 12 months post-surgery

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07174921
Responsible party
Ozan Karadeniz (Principal Investigator, Başakşehir Çam & Sakura City Hospital) — Principal investigator
First posted
Sep 16, 2025
Start date
Sep 30, 2025 (estimated)
Primary completion
Sep 30, 2026 (estimated)
Completion
Oct 15, 2026 (estimated)
Last update
Sep 16, 2025

Study contacts

Ozan Karadeniz, MD
Contact
dr.ozankrdnz@gmail.com
+905333663003

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion